25
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Use of a digital phantom developed by QIBA for harmonizing SUVs obtained from the state-of-the-art SPECT/CT systems: a multicenter study

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Although quantitative analysis using standardized uptake value (SUV) becomes realistic in clinical single-photon emission computed tomography/computed tomography (SPECT/CT) imaging, reconstruction parameter settings can deliver different quantitative results among different SPECT/CT systems. This study aims to propose a use of the digital reference object (DRO), which is a National Electrical Manufacturers Association (NEMA) phantom-like object developed by the Quantitative Imaging Biomarker Alliance (QIBA) fluorodeoxyglucose-positron emission tomography technical committee, for the purpose of harmonizing SUVs in Tc-99m SPECT/CT imaging.

          Methods

          The NEMA body phantom with determined Tc-99m concentration was scanned with the four state-of-the-art SPECT/CT systems. SPECT data were reconstructed using different numbers of the product of subset and iteration numbers ( SI) and the width of 3D Gaussian filter (3DGF). The mean (SUV mean), maximal (SUV max), and peak (SUV peak) SUVs for six hot spheres (10, 13, 17, 22, 28, and 37 mm) were measured after converting SPECT count into SUV using Becquerel calibration factor. DRO smoothed by 3DGF with a FWHM of 17 mm (DRO 17 mm) was generated, and the corresponding SUVs were measured. The reconstruction condition to yield the lowest root mean square error (RMSE) of SUV means for all the spheres between DRO 17 mm and actual phantom images was determined as the harmonized condition for each SPECT/CT scanner. Then, inter-scanner variability in all quantitative metrics was measured before (i.e., according to the manufacturers’ recommendation or the policies of their own departments) and after harmonization.

          Results

          RMSE was lowest in the following reconstruction conditions: SI of 100 and 3DGF of 13 mm for Brightview XCT, SI of 160 and 3DGF of 3 pixels for Discovery NM/CT, SI of 60 and 3DGF of 2 pixels for Infinia, and SI of 140 and 3DGF of 15 mm for Symbia. In pre-harmonized conditions, coefficient of variations (COVs) among the SPECT/CT systems were greater than 10% for all quantitative metrics in three of the spheres, SUV max and SUV mean, in one of the spheres. In contrast, all metrics except SUV max in the 17-mm sphere yielded less than 10% of COVs after harmonization.

          Conclusions

          Our proposed method clearly reduced inter-scanner variability in SUVs. A digital phantom developed by QIBA would be useful for harmonizing SUVs in multicenter trials using SPECT/CT.

          Related collections

          Most cited references30

          • Record: found
          • Abstract: found
          • Article: not found

          Quantitative accuracy of clinical 99mTc SPECT/CT using ordered-subset expectation maximization with 3-dimensional resolution recovery, attenuation, and scatter correction.

          We present a calibration method of a clinical SPECT/CT device for quantitative (99m)Tc SPECT. We use a commercially available reconstruction package including ordered-subset expectation maximization (OSEM) with depth-dependent 3-dimensional resolution recovery (OSEM-3D), CT-based attenuation correction, and scatter correction. We validated the method in phantom studies and applied it to images from patients injected with (99m)Tc-diphosponate. The following 3 steps were performed to derive absolute quantitative values from SPECT reconstructed images. In step 1, we used simulations to characterize the SPECT/CT system and derive emission recovery values for various imaging parameter settings. We simulated spheres of varying diameters and focused on the dependencies of activity estimation errors on structure size and position, pixel size, count density, and reconstruction parameters. In step 2, we cross-calibrated our clinical SPECT/CT system with the well counter using a large cylinder phantom. This step provided the mapping from image counts to kBq/mL. And in step 3, correction factors from steps 1 and 2 were applied to reconstructed images. We used a cylinder phantom with variable-sized spheres for verification of the method. For in vivo validation, SPECT/CT datasets from 16 patients undergoing (99m)Tc-diphosponate SPECT/CT examinations of the pelvis including the bladder were acquired. The radioactivity concentration in the patients' urine served as the gold standard. Mean quantitative accuracy and SEs were calculated. In the phantom experiments, the mean accuracy in quantifying radioactivity concentration in absolute terms was within 3.6% (SE, 8.0%), with a 95% confidence interval between -19.4% and +12.2%. In the patient studies, the mean accuracy was within 1.1% (SE, 8.4%), with a 95% confidence interval between -15.4% and +17.5%. Current commercially available SPECT/CT technology using OSEM-3D reconstruction, scatter correction, and CT-based attenuation correction allows quantification of (99m)Tc radioactivity concentration in absolute terms within 3.6% in phantoms and 1.1% in patients with a focus on the bladder. This opens up the opportunity of SPECT quantitation entering the routine clinical arena. Still, the imprecision caused by unavoidable measurement errors is a dominant factor for absolute quantitation in a clinical setup.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Pre-therapeutic dosimetry of normal organs and tissues of (177)Lu-PSMA-617 prostate-specific membrane antigen (PSMA) inhibitor in patients with castration-resistant prostate cancer.

            (177)Lu-617-prostate-specific membrane antigen (PSMA) ligand seems to be a promising tracer for radionuclide therapy of progressive prostate cancer. However, there are no published data regarding the radiation dose given to the normal tissues. The aim of the present study was to estimate the pretreatment radiation doses in patients who will undergo radiometabolic therapy using a tracer amount of (177)Lu-labeled PSMA ligand.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Harmonizing SUVs in multicentre trials when using different generation PET systems: prospective validation in non-small cell lung cancer patients

              Purpose We prospectively evaluated whether a strategy using point spread function (PSF) reconstruction for both diagnostic and quantitative analysis in non-small cell lung cancer (NSCLC) patients meets the European Association of Nuclear Medicine (EANM) guidelines for harmonization of quantitative values. Methods The NEMA NU-2 phantom was used to determine the optimal filter to apply to PSF-reconstructed images in order to obtain recovery coefficients (RCs) fulfilling the EANM guidelines for tumour positron emission tomography (PET) imaging (PSFEANM). PET data of 52 consecutive NSCLC patients were reconstructed with unfiltered PSF reconstruction (PSFallpass), PSFEANM and with a conventional ordered subset expectation maximization (OSEM) algorithm known to meet EANM guidelines. To mimic a situation in which a patient would undergo pre- and post-therapy PET scans on different generation PET systems, standardized uptake values (SUVs) for OSEM reconstruction were compared to SUVs for PSFEANM and PSFallpass reconstruction. Results Overall, in 195 lesions, Bland-Altman analysis demonstrated that the mean ratio between PSFEANM and OSEM data was 1.03 [95 % confidence interval (CI) 0.94–1.12] and 1.02 (95 % CI 0.90–1.14) for SUVmax and SUVmean, respectively. No difference was noticed when analysing lesions based on their size and location or on patient body habitus and image noise. Ten patients (84 lesions) underwent two PET scans for response monitoring. Using the European Organization for Research and Treatment of Cancer (EORTC) criteria, there was an almost perfect agreement between OSEMPET1/OSEMPET2 (current standard) and OSEMPET1/PSFEANM-PET2 or PSFEANM-PET1/OSEMPET2 with kappa values of 0.95 (95 % CI 0.91–1.00) and 0.99 (95 % CI 0.96–1.00), respectively. The use of PSFallpass either for pre- or post-treatment (i.e. OSEMPET1/PSFallpass-PET2 or PSFallpass-PET1/OSEMPET2) showed considerably less agreement with kappa values of 0.75 (95 % CI 0.67–0.83) and 0.86 (95 % CI 0.78–0.94), respectively. Conclusion Protocol-optimized images and compliance with EANM guidelines allowed for a reliable pre- and post-therapy evaluation when using different generation PET systems. These data obtained in NSCLC patients could be extrapolated to other solid tumours. Electronic supplementary material The online version of this article (doi:10.1007/s00259-013-2391-1) contains supplementary material, which is available to authorized users.
                Bookmark

                Author and article information

                Contributors
                +81-3-5363-3837 , nakahara@rad.med.keio.ac.jp
                daisaki@gchs.ac.jp
                yasushi@med.shimane-u.ac.jp
                iimori@chiba-u.jp
                kazuyuki_miyagawa@khsc.or.jp
                t.okamoto@tsgren.jp
                yoshiki.owaki@adst.keio.ac.jp
                yata@med.shimane-u.ac.jp
                k.sawada@chiba-u.jp
                ryotaro_tokorodani@khsc.or.jp
                jinzaki@rad.med.keio.ac.jp
                Journal
                EJNMMI Res
                EJNMMI Res
                EJNMMI Research
                Springer Berlin Heidelberg (Berlin/Heidelberg )
                2191-219X
                20 June 2017
                20 June 2017
                2017
                : 7
                : 53
                Affiliations
                [1 ]ISNI 0000 0004 1936 9959, GRID grid.26091.3c, Department of Radiology, , Keio University School of Medicine, ; 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582 Japan
                [2 ]GRID grid.443584.a, Department of Radiological Technology, , Gunma Prefectural College of Health Sciences, ; 323-1 Kamioki-machi, Maebashi, Gunma 371-0052 Japan
                [3 ]GRID grid.412567.3, Department of Radiology, , Shimane University Hospital, ; 89-1 Enya-cho, Izumo, Shimane 693-8501 Japan
                [4 ]ISNI 0000 0004 0632 2959, GRID grid.411321.4, Department of Radiology, , Chiba University Hospital, ; 1-8-1 Inohana, Chuo-ku, Chiba-shi, Chiba, 260-8677 Japan
                [5 ]ISNI 0000 0004 1769 1768, GRID grid.415887.7, Department of Radiology, , Kochi Medical Hospital, ; 2125-1 Ike, Kochi-shi, Kochi, 781-8555 Japan
                [6 ]Department of Radiology, Tsugaru General Hospital, 12-3 Iwaki-machi, Goshogawara-shi, Aomori, 037-0074 Japan
                [7 ]ISNI 0000 0001 1090 2030, GRID grid.265074.2, Department of Radiological Sciences, , Tokyo Metropolitan University, ; 7-2-10 Higashiogu, Arakawa-ku, Tokyo, 116-8551 Japan
                Author information
                http://orcid.org/0000-0002-7382-0806
                Article
                300
                10.1186/s13550-017-0300-5
                5479776
                28639254
                46e350c3-d09f-4112-b8b6-d175113012be
                © The Author(s). 2017

                Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

                History
                : 31 March 2017
                : 6 June 2017
                Categories
                Preliminary Research
                Custom metadata
                © The Author(s) 2017

                Radiology & Imaging
                spect/ct,harmonization,suv,multicenter study
                Radiology & Imaging
                spect/ct, harmonization, suv, multicenter study

                Comments

                Comment on this article